The rationale, design and baseline data of FLOW, a kidney outcomes trial with once-weekly semaglutide in people with type 2 diabetes and chronic kidney disease
Although you might see them referred to as GLP-1 patches, they dont actually contain any GLP-1 medication (or any licensed medications, for that matter)
Although not approved specifically for PCOS, GLP-1 RA use in women with PCOS has been associated with improved blood glucose control and weight loss, as well as improvements in menstrual regularity and a decrease in ovarian cysts ( 4 , 6 8 )
Not recommended for individuals with heart disease, uncontrolled high blood pressure, seizure disorder, hyperthyroidism, glaucoma, or those taking SSRIs or MAOIs
While it is not a pharmaceutical substitute, it does deliver on its positioning as a plant-based, science-inspired wellness product